Acute myeloid leukemia trials in Singapore

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Where

  Singapore

  Age

  12 years and over

  People

  468 worldwide

  Run by

  Syndax Pharmaceuticals

  See details and how to joinNCT07211958 · EU 2025-522279-27-00
• Phase 1/2Taking people
  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Where

  Singapore

  Age

  12 years and over

  People

  606 worldwide

  Run by

  Sumitomo Pharma America, Inc.

  See details and how to joinNCT04988555